Madeleine covers PCR, nucleic acid amplification, and sample prep technologies for GenomeWeb.
The sequencing-based, laboratory-developed test, called SmartJane, contains the first commercially available vaginal microbiome assay.
The reagent, which was tested on Bio-Rad's Droplet Digital PCR platform, could prove useful for quality control of clinical dPCR applications.
The Finnish firm provided updates on its isothermal amplification-based molecular diagnostics technology as well as its broader diagnostics business.
The recent study highlights strengths and weaknesses of numerous platforms and may help end users choose the best assay for their circumstances.
A new assay uses digital loop-mediated isothermal amplification (dLAMP) to perform phenotypic antibacterial susceptibility testing in 30 minutes.
The firm, which started in immunodiagnostics, is constructing a new building to house its molecular biology business.
The approach is based on a new approval of the BacT/ALERT Virtuo system and new indications for the firm's procalcitonin assay.
The firm recently presented data on its first two products that use its proprietary 3Base technology.
The company was founded earlier this year based on an improved method for multiple displacement amplification and a single-cell-variant caller.
The test was approved for lab use, but it runs on a platform with the potential for point-of-care applications.
Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.
Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.
The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.
In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.